Status:
COMPLETED
Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness
Lead Sponsor:
Manhattan Psychiatric Center
Collaborating Sponsors:
Eli Lilly and Company
Conditions:
Schizophrenia
Schizoaffective Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Obesity is increasing at an alarming rate in patients with schizophrenia, possibly in association with the increased use of atypical antipsychotics. In order to address the weight and metabolic syndro...
Detailed Description
The present program is divided into five detailed segments with three progressive levels, that provide a manualized lesson-by-lesson curriculum for implementation on the treatment mall. * Medication ...
Eligibility Criteria
Inclusion
- Are at lease 18 years of age; ≤ 65 years.
- Are male or female
- Are currently hospitalized at Manhattan Psychiatric Center and attend daily treatment mall programs.
- Are fluent in the language of the investigator, and study staff (including testing administrators, group leaders and supervisors)
- Have a documented current psychiatric diagnosis as obtained from patient's medical charts and recorded by a qualified psychiatrist.
- Recently admitted patients will be included if their clinical state permits it.
Exclusion
- Are \> 65 years of age;
- Are currently enrolled in the Intensive Psychiatric Services (IPS) program at Manhattan Psychiatric Center;
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
295 Patients enrolled
Trial Details
Trial ID
NCT00661869
Start Date
September 1 2006
End Date
January 1 2008
Last Update
August 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manhattan Psychiatric Center
New York, New York, United States, 10035